| abstract |
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I n n n n n n n n n n or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders. |